SLGL
NASDAQ
$89.74
Sol-Gel Technologies Ltd (SLGL)
Sol-Gel Technologies Ltd., a specialty clinical-stage pharmaceutical company, is focused on developing and commercializing topical dermatological pharmaceuticals based on its Israel-patented microencapsulation delivery system. The company is headquartered in Ness Ziona, Israel.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $193 (+115.07%)
Market Cap
$215M
Free Cash Flow Yield
0.13%
Beta (5Y)
0.74
Price Chart
Valuation
Market Cap$215M
Forward P/E9.34
P/S13.67
P/B4.78
Profitability
Total Revenue (TTM)$3.80M
Gross Profit (TTM)$1.72M
EBITDA-$7.43M
Profit Margin-5.7%
Operating Margin-3569%
EPS-$2.20
Financial Health
Free Cash Flow Yield0.13%
Growth & Risk
Revenue 5Y CAGR-15.21%
Beta (5Y)0.74
Sharpe Ratio2.83